340B Program: PhRMA Files Court Challenge to Final Rule on Orphan Drug Exception
04 October 2013Health, Pharmaceutical, and Biotechnology Alert
This past Friday, September 27, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed suit against the Department of Health and Human Services (HHS) challenging the 340B orphan drug final rule. The complaint seeks both to invalidate the final rule as well as to enjoin (stop) its implementation.
Read More: 340B Program: PhRMA Files Court Challenge to Final Rule on Orphan Drug Exception